StartOffer checks
Some words on an offer need a pause.
Read the offer slowly enough to separate a product claim from a care plan. A label or a seal cannot do that work for you.
Approval words need a record behind them.
By September 28, 2026, no medicine containing thymosin alpha-1 had received FDA approval.
The FDA, the U.S. drug review agency, does not approve clinics or doctors’ offices.
The rules about approval and business records below were checked September 26, 2026.
- A compounded medicine, made by a pharmacy for a patient, cannot truthfully be described as FDA-approved.
- “FDA registered” means a business has put its details in the FDA’s records. That does not mean the FDA approved the business or its product.
- A government drug code also does not establish product approval.
“For research use only” does not mean approved for treatment.
The FDA records below were checked September 26, 2026. Words such as “for research use only” do not settle whether a product is a drug under U.S. law.
The FDA has told sellers that health claims and accessories for injection can show an intent to supply a drug for people.
- Pause if a product says “for research use only” but comes with instructions for use in people.
- Ask the clinician to show the U.S. approval record for this medicine, or the ingredient rule that permits the pharmacy to make it.
- Ask who prepares it, and check the pharmacy record.
Study reports are not a guarantee about an offered product.
In its review, the FDA described soreness, redness, or irritation where the medicine was injected as the most common reported side effects.
Those studies used prepared medicines under medical supervision. They do not establish the quality of an unapproved product offered online.
The FDA raised concerns about unwanted substances and clumping in pharmacy-made thymosin alpha-1, and the body reacting to it as an invader.
- Ask how the actual preparation is checked.
- Ask which concerns apply to your health history.
- Ask what follow-up is offered if a problem occurs.
Personal concerns belong in the assessment.
There is no U.S. prescribing label for this drug: instructions for clinicians reviewed by the FDA. So there is no FDA-reviewed list of cautions about pregnancy or how it and your other medicines might affect each other.
The FDA’s account of the Italian drug instructions says the medicine must not be used during pregnancy or breastfeeding. It also calls for caution with a history of allergies.
It also urges caution alongside other medicines that act on the body’s defence system.
Those instructions from another country cannot decide whether a U.S. care offer is right for you.
- Bring these topics to the clinician if they apply to you.
- Ask how other medicines and your health history affect the decision.